Thus, a better understanding of the VISTA expression in diseased animals and FMC samples could reveal not only new non-invasive diagnostic or prognostic biomarkers but also improved options as therapeutic targets for cats with mammary carcinoma. The gene discussed is VSIR; the disease is breast carcinoma.